How do psychiatric patients perceive the side effects of their medications

Aims: Available instruments for the assessment of medication side effects give limited information about the overall impact of medication side effects on patient well-being. We have developed a scale to assess adverse drug events that can potentially be used in any field of medicine. Methods: A convenience sample of 61 consecutive psychiatric patients was enrolled from a rehabilitation clinic. The Side Effect Survey (SidES), designed for this study, was used to assess adverse drug effects. The Udvalg for Kliniske Undersogelser (UKU) Side Effect Rating Scale was used independently as another tool to assess medication side effects. Results: Overall reliability of the scale was good with Cronbach-alpha 0.81-0.96. Criterion-related validity of SidES was analyzed through a comparison of corresponding items in SidES with the UKU Side Effect Rating Scale. For 41 of 48 symptoms, there was a correlation between similar items in UKU and SidES at p<0.01. The total scores of SidES and the number of medications taken by the patients correlated at r=0.49, and r=0.43, p<0.0001. Conclusion: In this study SidES demonstrated good psychometric properties. Assessment of the overall impact of medication side effect could be useful for the development of safer medications and treatment regimens (German J Psychiatry 2006;9:74-93).

[1]  B. Psaty,et al.  Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis , 2004 .

[2]  J F Gallelli,et al.  Development of a Questionnaire for Detecting Potential Adverse Drug Reactions , 1992, The Annals of pharmacotherapy.

[3]  David Khayat,et al.  Changing patient perceptions of the side effects of cancer chemotherapy , 2002, Cancer.

[4]  J. Kalachnik.  Measuring side effects of psychopharmacologic medication in individuals with mental retardation and developmental disabilities , 1999 .

[5]  W. Fleischhacker,et al.  Compliance with antipsychotic drug treatment: influence of side effects. , 1994, Acta psychiatrica Scandinavica. Supplementum.

[6]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[7]  M. Rawlins,et al.  Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. , 2000, Journal of hepatology.

[8]  P. Weiden,et al.  An Innovative Approach to Clinical Communication in Schizophrenia: The Approaches to Schizophrenia Communication Checklists , 2001, CNS Spectrums.

[9]  K. Michels.  Problems Assessing Nonserious Adverse Drug Reactions: Antidepressant Drug Therapy and Sexual Dysfunction , 1999, Pharmacotherapy.

[10]  E. Lindström,et al.  Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat) , 2001, Nordic journal of psychiatry.

[11]  M. Pirmohamed,et al.  Reporting of adverse drug reactions by nurses , 2003, The Lancet.

[12]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[13]  J. Rabkin,et al.  General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. , 1992, Journal of clinical psychopharmacology.

[14]  R. Bentall,et al.  A Self-Rating Scale for Measuring Neuroleptic Side-Effects , 1995, British Journal of Psychiatry.

[15]  Mph Dr. Syed Rizwanuddin Ahmad MD.  Adverse drug event monitoring at the food and drug administration , 2007, Journal of General Internal Medicine.

[16]  S. Jordan,et al.  Monitoring adverse drug reactions: scales, profiles, and checklists. , 2004, International nursing review.

[17]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[18]  Yusuke Tanigawara,et al.  MICROMEDEX® Healthcare Series , 2004 .

[19]  Sheena Derry,et al.  BMC Clinical Pharmacology BioMed Central BMC 1 2001, Clinical Pharmacology , 2001 .

[20]  O. Andersson.  Registration of side effects by means of a questionnaire. , 2009, Acta medica Scandinavica. Supplementum.

[21]  S. Bentzen,et al.  The need for adverse effects reporting standards in oncology clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  U. Ahlfors,et al.  The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.

[23]  G. Klerman,et al.  The effects of antihypertensive therapy on the quality of life. , 1986, The New England journal of medicine.

[24]  John P A Ioannidis,et al.  Improving Safety Reporting from Randomised Trials , 2002, Drug safety.

[25]  S Benjamin,et al.  How to examine patients using the Abnormal Involuntary Movement Scale. , 1988, Hospital & community psychiatry.